Forbes Highlights LucyRx and Abarca Health Strategic Combination as an Alternative to the Big Three PBMs

Forbes reported on the strategic combination of LucyRx and Abarca Health, two privately held, independent PBMs coming together to create Healthcare Revolution Partners and offer the market a clear alternative to the traditional PBM model.

The article highlights the combined organization’s national scale, more than 9 million members, complementary commercial and government market expertise, and continued leadership by David Blair and Jason Borschow. Forbes also places the announcement in the broader context of rising prescription drug costs, increased regulatory scrutiny, and growing demand for more transparency, accountability, affordability, and competition in pharmacy benefits.

Read the full article

Download the PBM Reform Readiness Checklist

Download the GLP-1 Planning Checklist